Form 4: Azitra COO Travis Whitfill Receives Stock Option Grant
Statement of Changes in Beneficial Ownership
Azitra, Inc. Chief Operating Officer Travis Whitfill was granted 64,300 stock options with an exercise price of $0.2127.
Summary
- Travis Whitfill, Chief Operating Officer of Azitra, Inc., was granted 64,300 stock options on April 20, 2026.
- The options have an exercise price of $0.2127 per share.
- The options are set to expire on April 20, 2036.
- The grant follows a standard vesting schedule over three years.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that carries no significant signal regarding company health or market sentiment.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential for future dilution of existing shareholders upon the exercise of these options.
Risks
- The value of the options is dependent on the future performance of Azitra's common stock price relative to the $0.2127 exercise price.
Future Outlook
The options vest over a three-year period, with one-third vesting on the first anniversary and the remainder vesting monthly thereafter, indicating a long-term retention incentive for the COO.
Industry Context
StockSavvy.ai notes that equity grants to C-suite executives in the biotechnology sector are standard practice to ensure leadership retention and align management with clinical and commercial milestones.
Comparison to Industry Standards
- The use of time-based vesting schedules is consistent with standard corporate governance practices for small-cap biotech firms.
- The grant size is relatively modest, reflecting typical compensation structures for mid-level executive roles in early-stage life sciences companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation | Grant of stock options to the Chief Operating Officer. | 04/20/2026 | Neutral; standard incentive alignment. |
Stakeholder Impact
- Shareholders may experience minor dilution if these options are exercised in the future.
Next Steps
- Vesting of the first tranche of options on April 20, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/20/2026 | Date of the stock option grant transaction. |
| 04/22/2026 | Date the Form 4 was signed and filed. |
| 04/20/2036 | Expiration date of the granted stock options. |
Keywords
Azitra, AZTR, Form 4, Insider Trading, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.